India approves first nasal COVID-19 vaccine for emergency use
India granted emergency approval for a nasal COVID-19 vaccine developed by Bharat Biotech, becoming the second country after China to do so, with the vaccine intended for use as a primary dose in adults aged 18 and above.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthIndia approves first nasal COVID-19 vaccine for emergency use
Sign in or subscribeBrowse free archive reportsIndia granted emergency approval for a nasal COVID-19 vaccine developed by Bharat Biotech, becoming the second country after China to do so, with the vaccine intended for use as a primary dose in adults aged 18 and above.